Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Acad Dermatol ; 83(1): 184-188, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31821858

ABSTRACT

Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.


Subject(s)
Drug Compounding , Drug Compounding/economics , Drug Compounding/standards , Drug-Related Side Effects and Adverse Reactions , Humans , Technology, Pharmaceutical/legislation & jurisprudence , United States , United States Food and Drug Administration
2.
J Am Acad Dermatol ; 83(1): 179-183, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31669439

ABSTRACT

Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. This article outlines the clinical indications and general principles related to the manufacture of topical and common formulations.


Subject(s)
Drug Compounding/methods , Drug Compounding/standards , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...